LFVN Lifevantage Corp
Healthcare · Pharmaceutical Preparations · Market cap: $63.0M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $34.9K | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $44.5K | $0 |
| 2023-Q3 | $217.7K | $0 |
| 2023-Q4 | $49.4K | $33.0K |
| 2024-Q1 | $4.3K | $0 |
| 2024-Q2 | $3.6K | $0 |
| 2024-Q3 | $10.9K | $0 |
| 2024-Q4 | $3.6K | $0 |
| 2025-Q1 | $0 | $364.6K |
| 2025-Q2 | $16.6K | $0 |
| 2025-Q3 | $4.9K | $86.2K |
| 2025-Q4 | $5.3K | $330.5K |
| 2026-Q1 | $178.6K | $0 |
| 2026-Q2 | $6.1K | $85.5K |
| 2026-Q3 | $6.1K | $55.6K |
| 2026-Q4 | $0 | $0 |
Bought$586.3K32 buy days
Sold$1.0M13 sell days
Net insider flow-$416.5Knet selling · 5 years
Latest trade2026-09-15Lewis Darwin
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Buy | Lewis Darwin | Director | 976 | $6.22 | $6.1K | 1 |
| 2026-09-14 | Sell | Cunningham Kristen | Other C-suite | 8,901 | $6.18 | $55.0K | 1 |
| 2026-09-11 | Sell | Cunningham Kristen | Other C-suite | 100 | $6.41 | $641 | 1 |
| 2026-06-15 | Buy | Lewis Darwin | Director | 705 | $8.60 | $6.1K | 1 |
| 2026-06-03 | Sell | BEINDORFF MICHAEL A | Director | 10,000 | $8.55 | $85.5K | 1 |
| 2026-03-16 | Buy | Lewis Darwin | Director | 1,055 | $5.23 | $5.5K | 1 |
| 2026-03-02 | Buy | Dayton Judd | Director | 10,500 | $4.53 | $47.6K | 1 |
| 2026-02-27 | Buy | Dayton Judd | Director | 18,097 | $4.63 | $83.8K | 1 |
| 2026-02-26 | Buy | Dayton Judd | Director | 4,600 | $4.58 | $21.1K | 1 |
| 2026-02-09 | Buy | Lewis Darwin | Director | 3,955 | $5.22 | $20.6K | 1 |
| 2025-12-15 | Buy | Lewis Darwin | Director | 805 | $6.54 | $5.3K | 1 |
| 2025-11-19 | Sell | BEINDORFF MICHAEL A | Director | 12,607 | $6.42 | $80.9K | 1 |
| 2025-11-07 | Sell | BEINDORFF MICHAEL A | Director | 36,000 | $6.93 | $249.5K | 2 |
| 2025-09-16 | Buy | Lewis Darwin | Director | 450 | $10.85 | $4.9K | 1 |
| 2025-09-09 | Sell | BEINDORFF MICHAEL A | Director | 4,325 | $11.44 | $49.5K | 2 |
| 2025-07-01 | Sell | Aure Carl | CFO | 2,746 | $13.39 | $36.8K | 1 |
| 2025-06-13 | Buy | Lewis Darwin | Director | 379 | $12.86 | $4.9K | 2 |
| 2025-05-09 | Buy | Mauro Garry Paul | Director | 958 | $12.25 | $11.7K | 3 |
| 2025-02-10 | Sell | Greer Raymond B | Director | 8,000 | $20.15 | $161.2K | 1 |
| 2025-02-10 | Sell | BEINDORFF MICHAEL A | Director | 5,850 | $19.54 | $114.3K | 1 |
| 2025-02-10 | Sell | Latham Cynthia | Director | 4,450 | $20.02 | $89.1K | 1 |
| 2024-12-16 | Buy | Lewis Darwin | Director | 227 | $16.00 | $3.6K | 1 |
| 2024-09-17 | Buy | Lewis Darwin | Director | 351 | $10.31 | $3.6K | 2 |
| 2024-09-03 | Buy | Mauro Garry Paul | Director | 976 | $7.41 | $7.2K | 3 |
| 2024-06-14 | Buy | Lewis Darwin | Director | 489 | $7.38 | $3.6K | 2 |
| 2024-03-15 | Buy | Lewis Darwin | Director | 449 | $7.00 | $3.1K | 2 |
| 2024-02-02 | Buy | Mauro Garry Paul | Director | 199 | $5.67 | $1.1K | 2 |
| 2023-12-15 | Buy | Lewis Darwin | Director | 460 | $6.78 | $3.1K | 2 |
| 2023-11-20 | Sell | BEINDORFF MICHAEL A | Director | 5,500 | $6.00 | $33.0K | 1 |
| 2023-11-16 | Buy | Mauro Garry Paul | Director | 7,752 | $4.75 | $36.8K | 3 |
| 2023-11-15 | Buy | Mauro Garry Paul | Director | 2,024 | $4.65 | $9.4K | 1 |
| 2023-09-22 | Buy | Lewis Darwin | Director | 4,124 | $6.94 | $28.6K | 1 |
| 2023-09-05 | Buy | Mauro Garry Paul | Director | 1,000 | $7.63 | $7.6K | 7 |
| 2023-08-25 | Buy | Sudbury Capital Fund, LP | Other | 5,490 | $4.95 | $27.2K | 1 |
| 2023-08-24 | Buy | Sudbury Capital Fund, LP | Other | 7,226 | $4.82 | $34.8K | 1 |
| 2023-08-23 | Buy | Sudbury Capital Fund, LP | Other | 3,788 | $4.76 | $18.0K | 1 |
| 2023-08-11 | Buy | Radoff Bradley Louis | Other | 20,000 | $5.07 | $101.4K | 1 |
| 2023-05-25 | Buy | BEINDORFF MICHAEL A | Director | 2,000 | $4.21 | $8.4K | 1 |
| 2023-05-24 | Buy | BEINDORFF MICHAEL A | Director | 3,000 | $4.40 | $13.2K | 1 |
| 2023-05-12 | Buy | Mauro Garry Paul | Director | 150 | $4.21 | $632 | 1 |
| 2023-05-10 | Buy | Mauro Garry Paul | Director | 4,500 | $4.08 | $18.4K | 6 |
| 2023-05-09 | Buy | Lewis Darwin | Director | 1,000 | $3.88 | $3.9K | 1 |
| 2022-02-07 | Buy | BEINDORFF MICHAEL A | Director | 7,193 | $4.85 | $34.9K | 1 |
| 2021-12-08 | Sell | BEINDORFF MICHAEL A | Director | 5,143 | $6.62 | $34.0K | 1 |
| 2021-12-07 | Sell | BEINDORFF MICHAEL A | Director | 2,000 | $6.63 | $13.3K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| BEINDORFF MICHAEL A | Director | $56.5K | $660.0K | 2026-06-03 |
| Dayton Judd | Director | $232.5K | $0 | 2026-03-02 |
| Greer Raymond B | Director | $0 | $161.2K | 2025-02-10 |
| Lewis Darwin | Director | $102.9K | $0 | 2026-09-15 |
| Radoff Bradley Louis | Other | $101.4K | $0 | 2023-08-11 |
| Mauro Garry Paul | Director | $93.0K | $0 | 2025-05-09 |
| Latham Cynthia | Director | $0 | $89.1K | 2025-02-10 |
| Cunningham Kristen | Other C-suite | $0 | $55.6K | 2026-09-14 |
| Aure Carl | CFO | $0 | $36.8K | 2025-07-01 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-08-11 → 2023-09-22 | 4 | $217.7K | 39 | +15.3% (+10.1% raw) | -0.7% (+0.3% raw) | -7.0% (+5.2% raw) | closed |
| 2023-05-09 → 2023-05-25 | 3 | $44.5K | 34 | -11.0% (-5.3% raw) | +36.1% (+42.9% raw) | +48.3% (+49.8% raw) | closed |
| 2017-09-12 → 2017-09-15 | 3 | $39.8K | 49 | +30.3% (+34.7% raw) | +11.0% (+18.7% raw) | -16.0% (-6.3% raw) | closed |
| 2017-02-13 → 2017-02-14 | 6 | $72.8K | 57 | -21.3% (-21.1% raw) | -30.8% (-32.9% raw) | -52.8% (-52.6% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.